中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2009年
11期
737-741
,共5页
李洁颖%晏勇%蔡志友%冯占辉%张华%吴芳%孟涛%代政伟
李潔穎%晏勇%蔡誌友%馮佔輝%張華%吳芳%孟濤%代政偉
리길영%안용%채지우%풍점휘%장화%오방%맹도%대정위
阿尔茨海默病%海马%1-磷脂酰肌醇3-激酶%蛋白质丝氨酸苏氨酸激酶%天冬氨酸内肽酶类%淀粉样前体蛋白分泌酶类%胰岛素
阿爾茨海默病%海馬%1-燐脂酰肌醇3-激酶%蛋白質絲氨痠囌氨痠激酶%天鼕氨痠內肽酶類%澱粉樣前體蛋白分泌酶類%胰島素
아이자해묵병%해마%1-린지선기순3-격매%단백질사안산소안산격매%천동안산내태매류%정분양전체단백분비매류%이도소
Alzheimer disease%Hippocampus%1-Phosphatidylinositol 3-kinase%Proteinserine-threonine kinases%Aspartic endopeptidases%Amyloid precursor protein secretases%Insulin
目的 通过胰岛素和磷脂酰肌醇-3激酶(PDK)抑制剂渥曼青霉素(wortmannin,WORT)对PI3K/丝氨酸苏氨酸蛋白激酶(PDK/Akt)信号通路的激活和抑制作用,观察PI3K/Akt信号通路对海马神经元B-淀粉样前体蛋白裂解酶1(BACE1)表达的影响.方法 40只SD大鼠随机分为空白对照组、假手术组、胰岛素组和WORT组(每组10只),海马立体定向注射胰岛素和PI3K抑制剂WORT.免疫组织化学和Western blot法检测PI3K/Akt信号传导相关蛋白以及BACE1的表达水平.结果 注射胰岛素的海马PI3K信号通路下游信号分子较对照组:Akt表达增加(0.952±0.060与0.835±0.029,t=4.9150,P=0.0001),Akt set473位点磷酸化(pAkt)水平上调(0.800±0.075与0.657±0.025,t=4.5598,P=0.0002),糖原合成激酶-3α(GSK-3α)磷酸化水平降低(0.604±0.062与0.726±0. 041,t=3.5871,P=0.0018),而成熟的BACE1及其裂解产物β分泌酶C末端(β-CTF)表达下调.WORT组的PI3K下游信号分子Akt、pAkt表达明显被抑制,磷酸化GSK-3α表达增加,同时成熟的BACE1(1.004±0.096)和β-CTF(1.031±0.048)的表达较对照组(分别0.498±0.064,0.786±0.101)上调(分别t=11.5980,P=0.0000;t=4.2194,P=0.0004).结论 胰岛素信号通路PI3K/AKt可以调节BACE1的表达和活性并参与阿尔茨海默病的发病机制.
目的 通過胰島素和燐脂酰肌醇-3激酶(PDK)抑製劑渥曼青黴素(wortmannin,WORT)對PI3K/絲氨痠囌氨痠蛋白激酶(PDK/Akt)信號通路的激活和抑製作用,觀察PI3K/Akt信號通路對海馬神經元B-澱粉樣前體蛋白裂解酶1(BACE1)錶達的影響.方法 40隻SD大鼠隨機分為空白對照組、假手術組、胰島素組和WORT組(每組10隻),海馬立體定嚮註射胰島素和PI3K抑製劑WORT.免疫組織化學和Western blot法檢測PI3K/Akt信號傳導相關蛋白以及BACE1的錶達水平.結果 註射胰島素的海馬PI3K信號通路下遊信號分子較對照組:Akt錶達增加(0.952±0.060與0.835±0.029,t=4.9150,P=0.0001),Akt set473位點燐痠化(pAkt)水平上調(0.800±0.075與0.657±0.025,t=4.5598,P=0.0002),糖原閤成激酶-3α(GSK-3α)燐痠化水平降低(0.604±0.062與0.726±0. 041,t=3.5871,P=0.0018),而成熟的BACE1及其裂解產物β分泌酶C末耑(β-CTF)錶達下調.WORT組的PI3K下遊信號分子Akt、pAkt錶達明顯被抑製,燐痠化GSK-3α錶達增加,同時成熟的BACE1(1.004±0.096)和β-CTF(1.031±0.048)的錶達較對照組(分彆0.498±0.064,0.786±0.101)上調(分彆t=11.5980,P=0.0000;t=4.2194,P=0.0004).結論 胰島素信號通路PI3K/AKt可以調節BACE1的錶達和活性併參與阿爾茨海默病的髮病機製.
목적 통과이도소화린지선기순-3격매(PDK)억제제악만청매소(wortmannin,WORT)대PI3K/사안산소안산단백격매(PDK/Akt)신호통로적격활화억제작용,관찰PI3K/Akt신호통로대해마신경원B-정분양전체단백렬해매1(BACE1)표체적영향.방법 40지SD대서수궤분위공백대조조、가수술조、이도소조화WORT조(매조10지),해마입체정향주사이도소화PI3K억제제WORT.면역조직화학화Western blot법검측PI3K/Akt신호전도상관단백이급BACE1적표체수평.결과 주사이도소적해마PI3K신호통로하유신호분자교대조조:Akt표체증가(0.952±0.060여0.835±0.029,t=4.9150,P=0.0001),Akt set473위점린산화(pAkt)수평상조(0.800±0.075여0.657±0.025,t=4.5598,P=0.0002),당원합성격매-3α(GSK-3α)린산화수평강저(0.604±0.062여0.726±0. 041,t=3.5871,P=0.0018),이성숙적BACE1급기렬해산물β분비매C말단(β-CTF)표체하조.WORT조적PI3K하유신호분자Akt、pAkt표체명현피억제,린산화GSK-3α표체증가,동시성숙적BACE1(1.004±0.096)화β-CTF(1.031±0.048)적표체교대조조(분별0.498±0.064,0.786±0.101)상조(분별t=11.5980,P=0.0000;t=4.2194,P=0.0004).결론 이도소신호통로PI3K/AKt가이조절BACE1적표체화활성병삼여아이자해묵병적발병궤제.
Objective To investigate the effect of phosphatidylinesitol-3 kinase/serine threonine kinase (PI3K/Akt) signaling pathway on expression of beta-site amyloid precursor protein cleaving enzyme-1 (BACE1) in the hippocampus neurons of rat brain. Methods Forty SD rats were randomly divided into 4 groups: blank control group, sham-operated group, insulin group and wortmannin group. Insulin or the specific inhibitor of PI3K, wortmannin was injected into hippocampus neurons to activate or inhibit the signaling pathway in insulin group or wortmannin group, respectively. Immunoprecipitation and Western blot were used to analyze the proteins levels of PI3K/Akt and BACE1. Results In insulin treatment group,among the proteins downstream of signaling pathway, expression of Akt increased (0. 952±0.060 vs 0.835±0.029,t=4.9150, P=0.0001), phospho-Akt set473 increased (0.800±0.075 vs 0.657± 0.025,t=4.5598, P=0.0002), phospho-GSK-3α decreased (0.604±0.062 vs 0.726±0.041, t= 3.5871, P=0.0018 ), and the expression of mature BACE1 and β-CTF significantly decreased. In wortmannin group, the expression of Akt and phospho-Akt ser473 were inhibited; phospho-GSK-3α increased ; mature BACEI (1.004±0.096) and β-CTF (1.031±0.048) increased (t=11.5980, P= 0.0000 and t =4.2194, P =0.0004, respectively). Conclusions PI3K/Akt signaling pathway might effect the expression of BACE1, in which impaired signaling pathway may cause the amyloid precursor protein to be easily processed by BACE1, and thus involves the pathology of Alzheimer' s disease.